Literature DB >> 2091732

Fungal infections in AIDS patients.

D A Stevens1.   

Abstract

The mycoses are of increasing importance because of the AIDS epidemic. Oral and other forms of candidosis are nearly universal in AIDS patients. Cryptococcosis is the most common lethal mycosis, and may number tens of thousands of cases in AIDS worldwide annually. As the number of AIDS patients mounts, a rising tide of infections due to nearly all recognised fungal pathogens is occurring; examples include histoplasmosis, coccidioidomycosis and penicilliosis. These experiences have led to an investigation of new drugs which are compatible with the understanding that AIDS patients presently have an incurable underlying disease; that is, the drugs would be oral (allowing outpatient management) and/or have low toxicity, and may still be useful if only as a suppressive. These investigations have thus far focused on the triazoles. The current status of the mycoses and AIDS is reviewed.

Entities:  

Mesh:

Year:  1990        PMID: 2091732

Source DB:  PubMed          Journal:  Br J Clin Pract Suppl        ISSN: 0262-8767


  14 in total

1.  Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients.

Authors:  A Schoofs; F C Odds; R Colebunders; M Ieven; H Goossens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

2.  Typing Candida albicans oral isolates from human immunodeficiency virus-infected patients by multilocus enzyme electrophoresis and DNA fingerprinting.

Authors:  P Boerlin; F Boerlin-Petzold; J Goudet; C Durussel; J L Pagani; J P Chave; J Bille
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

3.  CpG oligodeoxynucleotides promote the host protective response against infection with Cryptococcus neoformans through induction of interferon-gamma production by CD4+ T cells.

Authors:  K Miyagi; K Kawakami; Y Kinjo; K Uezu; T Kinjo; K Nakamura; A Saito
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

4.  Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans.

Authors:  K Kawakami; Y Kinjo; S Yara; Y Koguchi; K Uezu; T Nakayama; M Taniguchi; A Saito
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells.

Authors:  T Zhang; K Kawakami; M H Qureshi; H Okamura; M Kurimoto; A Saito
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

6.  Adhesion of Candida albicans to brain tissue of Macaca mulata in an ex vivo assay.

Authors:  F J Denaro; J L López-Ribot; W L Chaffin
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users.

Authors:  P Boerlin; F Boerlin-Petzold; C Durussel; M Addo; J L Pagani; J P Chave; J Bille
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

8.  Anticryptococcal effect of amphotericin B is mediated through macrophage production of nitric oxide.

Authors:  M Tohyama; K Kawakami; A Saito
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

Review 9.  Invasive oesophageal candidiasis: current and developing treatment options.

Authors:  Jose A Vazquez
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis.

Authors:  K V Clemons; E Brummer; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.